Scarica l'app Stockscreener
34.60
4.16%
-1.50
Dopo l'orario di chiusura:
34.00
-0.60
-1.73%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$36.10
Aprire:
$36.43
Volume 24 ore:
55,293
Relative Volume:
0.40
Capitalizzazione di mercato:
$547.27M
Reddito:
-
Utile/perdita netta:
$-61.23M
Rapporto P/E:
-2.5593
EPS:
-13.5194
Flusso di cassa netto:
$22.49M
1 W Prestazione:
-2.20%
1M Prestazione:
-5.75%
6M Prestazione:
+105.34%
1 anno Prestazione:
+124.97%
Intervallo 1D:
$34.22
$36.43
Intervallo di 1 settimana:
$34.22
$38.82
Portata 52W:
$7.75
$39.70
Assembly Biosciences Inc Stock (ASMB) Company Profile
Nome
Assembly Biosciences Inc
Settore
Industria
Telefono
(833) 409-4583
Indirizzo
TWO TOWER PLACE, SOUTH SAN FRANCISCO
Confronta ASMB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ASMB
Assembly Biosciences Inc
|
34.60 | 571.00M | 0 | -61.23M | 22.49M | -13.52 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.71 | 114.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.62 | 77.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
850.95 | 54.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.50 | 52.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
196.92 | 42.02B | 447.02M | -1.18B | -906.14M | -6.1812 |
Assembly Biosciences Inc Stock (ASMB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-24 | Iniziato | Citizens JMP | Mkt Outperform |
| 2025-08-18 | Ripresa | H.C. Wainwright | Buy |
| 2025-03-25 | Iniziato | Guggenheim | Buy |
| 2024-09-20 | Aggiornamento | Jefferies | Hold → Buy |
| 2021-09-13 | Iniziato | H.C. Wainwright | Neutral |
| 2021-09-02 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2021-03-23 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2020-11-06 | Downgrade | Jefferies | Buy → Hold |
| 2020-10-19 | Iniziato | Truist | Buy |
| 2019-10-16 | Iniziato | Mizuho | Buy |
| 2018-11-19 | Iniziato | Leerink Partners | Outperform |
| 2018-10-08 | Aggiornamento | B. Riley FBR | Neutral → Buy |
| 2018-08-08 | Iniziato | Robert W. Baird | Outperform |
| 2018-04-13 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| 2018-01-05 | Iniziato | B. Riley FBR, Inc. | Neutral |
| 2017-11-08 | Iniziato | Jefferies | Buy |
| 2017-05-30 | Iniziato | Chardan Capital Markets | Buy |
Mostra tutto
Assembly Biosciences Inc Borsa (ASMB) Ultime notizie
Assembly Biosciences Completes Key Phase 1a Study on ABI-6250 - TipRanks
(ASMB) and the Role of Price-Sensitive Allocations - news.stocktradersdaily.com
JANUS HENDERSON GROUP PLC Expands Stake in Assembly Biosciences Inc - GuruFocus
Assembly Biosciences (ASMB) Receives a Buy from Guggenheim - The Globe and Mail
Jefferies raises Assembly Biosciences stock price target to $62 on HSV data By Investing.com - Investing.com South Africa
Jefferies raises Assembly Biosciences stock price target to $62 on HSV data - Investing.com Nigeria
After-Hours Gainers: Exicure Tops List With 72% Jump, Wave Life And Assembly Biosciences Advance - Nasdaq
Assembly Biosciences stock rises after promising HSV drug results By Investing.com - Investing.com India
Assembly Biosciences Reports Positive Phase 1b Results - TipRanks
Assembly Biosciences stock rises after promising HSV drug results - Investing.com
Assembly Biosciences announces interim results from ABI-1179, ABI-5366 trials - TipRanks
Assembly Bio reports strong results for HSV treatments in trials By Investing.com - Investing.com India
Assembly Biosciences (ASMB) Reports Promising Phase 1b Interim R - GuruFocus
Assembly Biosciences Reports Positive Interim Results from Phase 1b Clinical Studies of Long-Acting Helicase-Primase Inhibitor Candidates ABI-1179 and ABI-5366 Showing Reductions in Viral Shedding Rate and Virologically Confirmed Genital Lesion Rat - The Manila Times
Assembly Biosciences, Inc. (NASDAQ:ASMB) Given Average Recommendation of “Moderate Buy” by Analysts - Defense World
Assembly Biosciences, Inc. (NASDAQ:ASMB) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Will Assembly Biosciences Inc. (V7B) stock beat growth indexesWeekly Gains Report & Precise Swing Trade Alerts - Newser
Why ETFs are accumulating Assembly Biosciences Inc. (V7B) stockGap Up & High Yield Stock Recommendations - Newser
Assembly Biosciences, Inc.'s (NASDAQ:ASMB) Shift From Loss To Profit - Yahoo Finance
Why Assembly Biosciences Inc. (V7B) stock is a strong analyst pick - Newser
Assembly Biosciences (NASDAQ:ASMB) Stock Price Down 8.3%Time to Sell? - MarketBeat
Responsive Playbooks and the ASMB Inflection - news.stocktradersdaily.com
Can Assembly Biosciences Inc. (V7B) stock test all time highsJuly 2025 Momentum & Safe Capital Growth Trade Ideas - Newser
Will Assembly Biosciences Inc. (V7B) stock see insider accumulationEarnings Recap Summary & AI Enhanced Trading Alerts - Newser
Financial Comparison: Assembly Biosciences (NASDAQ:ASMB) versus Evoke Pharma (NASDAQ:EVOK) - Defense World
Assembly Biosciences (NASDAQ:ASMB) Stock Price Crosses Above Two Hundred Day Moving AverageHere's Why - MarketBeat
Analyzing Evoke Pharma (NASDAQ:EVOK) & Assembly Biosciences (NASDAQ:ASMB) - Defense World
H.C. Wainwright Reaffirms Buy Rating on Assembly Biosciences, Inc. (ASMB) Amid Promising Trial Data - MSN
Analysts Offer Insights on Healthcare Companies: Exact Sciences (EXAS) and Assembly Biosciences (ASMB) - The Globe and Mail
Understanding the Setup: (ASMB) and Scalable Risk - news.stocktradersdaily.com
Will Assembly Biosciences Inc. stock outperform international peersWeekly Market Outlook & Smart Investment Allocation Tips - newser.com
What analysts say about Assembly Biosciences Inc stockCurrency Fluctuation Impact & Double Or Triple Investment - earlytimes.in
Mizuho Maintains Assembly Biosciences (ASMB) Outperform Recommendation - Nasdaq
Assembly Biosciences (ASMB) Sees Raised Price Target From Mizuho - GuruFocus
Assembly Biosciences price target raised to $40 from $29 at Mizuho - TipRanks
Mizuho Raises Price Target on Assembly Biosciences to $40 From $29, Keeps Outperform Rating - marketscreener.com
How buyback programs support Assembly Biosciences Inc. (V7B) stockEarnings Recap Report & Entry Point Confirmation Alerts - newser.com
How Assembly Biosciences Inc. (V7B) stock benefits from digital adoption2025 Risk Factors & Low Drawdown Momentum Ideas - newser.com
What drives Assembly Biosciences Inc V7B stock priceEarnings Per Share Trends & Fast Profit Investment Ideas - earlytimes.in
What to do if you’re stuck in Assembly Biosciences Inc.2025 Performance Recap & Fast Momentum Entry Tips - newser.com
Will Assembly Biosciences Inc. (V7B) stock benefit from Fed rate cuts2025 Price Targets & Weekly High Momentum Picks - newser.com
Is Assembly Biosciences Inc. (V7B) stock a buy during volatile marketsInsider Selling & Real-Time Stock Movement Alerts - newser.com
Is Assembly Biosciences Inc. stock a buy before product launches2025 Technical Patterns & Entry and Exit Point Strategies - newser.com
Assembly Biosciences Inc. stock momentum explainedWeekly Trade Recap & High Return Trade Guides - newser.com
Assembly Biosciences Inc Azioni (ASMB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.36%
1.05%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):